These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
184 related items for PubMed ID: 1329479
41. Comparison of captopril and ibopamine in mild to moderate heart failure. Dohmen HJ, Dunselman PH, Poole-Wilson PA. Heart; 1997 Sep; 78(3):285-90. PubMed ID: 9391292 [Abstract] [Full Text] [Related]
42. [Effectiveness of Lisinopril in the treatment of heart failure]. Ruszty L, Nagy A, Szónyi T, Vályi P, Poór F, Takács J, Zalaváry I. Orv Hetil; 2000 Aug 20; 141(34):1867-72. PubMed ID: 11006711 [Abstract] [Full Text] [Related]
43. Lisinopril. A review of its pharmacology and clinical efficacy in elderly patients. Langtry HD, Markham A. Drugs Aging; 1997 Feb 20; 10(2):131-66. PubMed ID: 9061270 [Abstract] [Full Text] [Related]
44. Randomised, double-blind crossover comparison of once-daily captopril and lisinopril in patients with mild to moderate hypertension--a community-based study. Hunter Hypertension Research Group. Clin Exp Hypertens; 1993 Mar 20; 15(2):423-34. PubMed ID: 8385526 [Abstract] [Full Text] [Related]
45. Progression of mild untreated heart failure during six months follow-up and clinical and neurohumoral effects of ibopamine and digoxin as monotherapy. DIMT Study Group. Dutch Ibopamine Multicenter Trial. van Veldhuisen DJ, Brouwer J, Man in 't Veld AJ, Dunselman PH, Boomsma F, Lie KI. Am J Cardiol; 1995 Apr 15; 75(12):796-800. PubMed ID: 7717282 [Abstract] [Full Text] [Related]
46. [Treatment with lisinopril or nifedipine in essential hypertension. A Norwegian multicenter study of the effect, tolerance and quality of life of 828 patients]. Syvertsen JO, Bratland B, Dahlöf B, Gisholt K, Os I, Tretli S. Tidsskr Nor Laegeforen; 1992 Nov 10; 112(27):3432-6. PubMed ID: 1334284 [Abstract] [Full Text] [Related]
48. Plasma concentration of Fas/Fas ligand and left ventricular function in response to metoprolol in conjunction with standard treatment. Hou YP, Wu JL, Fan Q, Liu MB, Yin BL, Zhang L. Clin Sci (Lond); 2007 Mar 10; 112(5):299-304. PubMed ID: 17020540 [Abstract] [Full Text] [Related]
49. The effects of enalapril-digoxin-diuretic combination therapy on nutritional and anthropometric indices in chronic congestive heart failure: preliminary findings in cardiac cachexia. Adigun AQ, Ajayi AA. Eur J Heart Fail; 2001 Jun 10; 3(3):359-63. PubMed ID: 11378008 [Abstract] [Full Text] [Related]
52. Safety and efficacy study of delapril versus enalapril in patients with congestive heart failure. Dalla-Volta S. Am J Cardiol; 1995 Jun 16; 75(18):44F-49F. PubMed ID: 7778534 [Abstract] [Full Text] [Related]
53. Effectiveness of digitoxin versus trichlormethiazide/amiloride in congestive heart failure NYHA class II/III and sinus rhythm. Huonker M, Sorichter S, Schmidt-Trucksäss A, Irmer M, Staiger J, Keul J. Cardiovasc Drugs Ther; 1999 May 16; 13(3):233-41. PubMed ID: 10439886 [Abstract] [Full Text] [Related]
56. Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial. Ahmed A, Rich MW, Fleg JL, Zile MR, Young JB, Kitzman DW, Love TE, Aronow WS, Adams KF, Gheorghiade M. Circulation; 2006 Aug 01; 114(5):397-403. PubMed ID: 16864724 [Abstract] [Full Text] [Related]
57. The hemodynamic and pharmacokinetic interactions between chronic use of oral levosimendan and digoxin in patients with NYHA Classes II-III heart failure. Harjola VP, Oikarinen L, Toivonen L, Jurkko R, Puttonen J, Sarapohja T, Sundberg S, Nieminen MS. Int J Clin Pharmacol Ther; 2008 Aug 01; 46(8):389-99. PubMed ID: 18793580 [Abstract] [Full Text] [Related]